DMC Biotechnologies, Inc.
DMC Biotechnologies is a US-based biomanufacturer revolutionizing chemical production through precision fermentation. They focus on sustainable, bio-based ingredients and specialty chemicals, leveraging their proprietary Dynamic Metabolic Control™ technology to produce high-quality, environmentally responsible products for markets including nutraceuticals, cosmetics, and specialty chemicals. Their mission is to decarbonize supply chains, promote health, and foster innovation in sustainable manufacturing.
Industries
Nr. of Employees
medium (51-250)
DMC Biotechnologies, Inc.
Products
D-chiro-inositol (fermentation-produced)
A fermentation-derived D-chiro-inositol ingredient produced using precision fermentation and solvent-free purification, intended for dietary supplements, food, and medical nutrition formulations.
Myo-inositol (fermentation-produced)
A fermentation-produced myo-inositol ingredient for health-focused formulations; publicly announced as commercially launched and made available to brands and formulators.
L-alanine (pilot and commercial demonstration)
An amino acid produced by fermentation with validated pilot- and commercial-scale performance, suitable as a bio-based chemical intermediate for nutrition and other markets.
Bio-based chemical intermediates and monomers (development pipeline)
Development of fermentation-derived specialty chemical intermediates and monomers for applications including personal care, materials, and industrial formulations.
D-chiro-inositol (fermentation-produced)
A fermentation-derived D-chiro-inositol ingredient produced using precision fermentation and solvent-free purification, intended for dietary supplements, food, and medical nutrition formulations.
Myo-inositol (fermentation-produced)
A fermentation-produced myo-inositol ingredient for health-focused formulations; publicly announced as commercially launched and made available to brands and formulators.
L-alanine (pilot and commercial demonstration)
An amino acid produced by fermentation with validated pilot- and commercial-scale performance, suitable as a bio-based chemical intermediate for nutrition and other markets.
Bio-based chemical intermediates and monomers (development pipeline)
Development of fermentation-derived specialty chemical intermediates and monomers for applications including personal care, materials, and industrial formulations.
Services
Collaborative development from concept through pilot and commercial scale including strain optimization, fermentation process development, and technology transfer to manufacturing sites.
Execution of downstream purification workflows and coordination with third-party purification partners to deliver high-purity product suitable for commercial qualification.
Provision and publication of a TEA calculator and methodologies to assess commercial feasibility, link process inputs to cost outputs, and prioritize projects.
Collaborative development from concept through pilot and commercial scale including strain optimization, fermentation process development, and technology transfer to manufacturing sites.
Execution of downstream purification workflows and coordination with third-party purification partners to deliver high-purity product suitable for commercial qualification.
Provision and publication of a TEA calculator and methodologies to assess commercial feasibility, link process inputs to cost outputs, and prioritize projects.
Expertise Areas
- Precision fermentation process development
- Metabolic engineering and strain design
- Bioprocess scale-up and technology transfer
- Downstream purification for small molecules
Key Technologies
- Precision fermentation
- Dynamic metabolic flux control
- Strain engineering and pathway optimization
- Pilot and commercial-scale stirred-tank fermentation (up to 85 m3)
News & Updates
A next-generation nutraceutical ingredient—cleaner, more sustainable, and ready for modern formulation needs.
A collaboration to develop a more sustainable, fermentation-produced, high volume chemical intermediate.
K’Lynne Johnson brings over 25 years of experience to DMC as Chair of the Board of Directors.
A new, sustainable ingredient for health-focused brands.
Recognized among the leading companies in sustainable innovation by Cleantech Group.
A next-generation nutraceutical ingredient—cleaner, more sustainable, and ready for modern formulation needs.
A collaboration to develop a more sustainable, fermentation-produced, high volume chemical intermediate.
K’Lynne Johnson brings over 25 years of experience to DMC as Chair of the Board of Directors.
A new, sustainable ingredient for health-focused brands.
Recognized among the leading companies in sustainable innovation by Cleantech Group.